H3R antagonist 4
H3R antagonist 4 (compound 11L) was a dual inhibitor of cholinesterase and histamine receptor (H3R), with corresponding IC50 of 7.04 μM (eeAChE), 9.73 μM (hAChE)(reversible) and 1.09 nM (H3R) , respectively. H3R antagonist 4 inhibited the aggregation of Aβ1-42 induced by itself and Cu2+ (95.48% and 88.63%) , and degraded the Aβ1-42 fibrils induced by itself and Cu2+ (80.16% and 89.30%) . H3R antagonist 4 chelate biometals such as Cu2+, Zn2+, Al3+, and Fe2+. H3R antagonist 4 significantly reduced tau protein hyperphosphorylation induced by Aβ1-42 and inhibited RSL-3-induced apoptosis and ferroptosis in PC12 cells. H3R antagonist 4 had the best blood-brain barrier permeability and intestinal absorption in hCMEC/D3 and hPepT1-MDCK cells.H3R antagonist 4 ameliorates learning and memory impairment in a mouse model of Alzheimer's disease induced by scopolamine (HY-N0296) .
For research use only. We do not sell to patients.
- Formula: C30H36N2O9
- Molecular Weight:568.61
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Histamine Receptor Isoforms
More
Biological Activity
Description
IC50 & Target
|
hAChE 9.73 μM (IC50) |
EeAChE 7.04 μM (IC50) |
eqBCHE 13.40 ~ 88 μM (IC50) |
In Vitro
H3R antagonist 4 (compound 11l) inhibited eeAChE, eqBuChE and hAChE with IC50 values of 7.04 μM, 13.40 μM and 9.73 μM, respectively[1].
H3R antagonist 4 combines with AChE and occupies CAS, midgorge site and PAS. It interacts with the active site and peripheral anion site of hAChE, and can bind both CAS and PAS sites as two-site AChE inhibitors[1].
H3R antagonist 4 inhibited the aggregation of Aβ1-42 induced by itself and Cu2+ (95.48% and 88.63%, respectively)(ThT fluorescence assay) , and degraded the Aβ1-42 fibrils induced by itself and Cu2+ (80.16% and 89.30% , respectively)(TEM) [1].
The IC50 of H3R antagonist 4 (TRFRET) was 1.09 nM[1].
H3R antagonist 4 (5 μM, 10 μM and 20 μM)(WB) inhibited abnormal tau phosphorylation in PC12 cells[1].
H3R antagonist 4 (11 μM) increased the survival rate of PC12 (800 μM H2O2) to 75.66%, and decreased the level of ROS. PC12 cells were protected from H2O2 by decreasing ROS accumulation, and the percentage of apoptotic cells was significantly increased to 22.9% ± 0.36%[1].
H3R antagonist 4 (5, 10, 20 μM) inhibited RSL3-induced iron death in PC12 cells and significantly increased cell viability. The induced injury increased the permeability of blood-brain barrier in vitro[1].
H3R antagonist 4 (UV-vis spectrometry) can sequester Cu 2+, Zn 2+, Al 3+ and Fe 2+ [1].
H3R antagonist 4 increased PEPT1 protein expression in hPepT1-MDCK cells[1].
H3R antagonist 4 (0-80 μM, 1h) showed anti-inflammatory effect in BV-2 cells and did not affect proliferation[1] .
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:PC12
-
Concentration:5, 10, 20 μM; Aβ25-35
-
Incubation Time:30 min
-
Result:Inhibited tau hyperphosphorylation, the relative protein expression of p-Tau (Thr 181)/Total-tau significantly increased.
-
Cell Line:PC12
-
Concentration:5, 10, 20 μM; H2O2, 800 μM, 4 h
-
Incubation Time:24 h
-
Result:Reduced the apoptosis of PC12 cells.
-
Cell Line:BV-2
-
Concentration:0 - 80 μM; LPS 10 μg/mL; treated with all result.
-
Incubation Time:1 h
-
Result:Reduced inflammation.
-
Cell Line:PC12
-
Concentration:5, 10, 20 µM; H2O2, 800 μM, 4 h
-
Incubation Time:24 h
-
Result:Increased cell viability to 75.66 %.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:AD mouse model[1]
-
Dosage:2.5 and 5.0 mg/kg
-
Administration:Intraperitoneal injection (i.p.)
-
Result:Reduced AChE activity and ACh levels increased in the rivastigmine.Hematoxylin and eosin (HE) staining showed that hippocampal cells in the model group were loosely arranged and disorganized, and that the number of cells was reduced.Significantly improved cognitive deficits and spatial memory in AD model mice. A good pharmacokinetic profile of H3R antagonist 4 was confirmed in an in vivo study [1].
-
Animal Model:SD mouse model (200-220 g)[1]
-
Dosage:Fasted for 12 h; 10 and 17 mg/kg
-
Administration:Intravenous injection (i.v.)
-
Result:Good blood-brain barrier permeability.
-
Animal Model:SD mouse model[1]
-
Dosage:1.25, 2.5, 5.0 mg/kg; scopolamine, 1.25 mg/kg, Intraperitoneal injection
-
Administration:i.g.
-
Result:Shortened the escape latency compared with the model group. Improved the learning and memory ability of scopolamine-injected mice [1].
Chemical Information
-
Molecular Weight 568.61
-
Formula C30H36N2O9
-
SMILES
CC(C)[C@@H](C(O)=O)NC(OC1=CC2=C(C(O)=C1O)C(C=C(C3=CC=C(OCCCN4CCCCCC4)C=C3)O2)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Protocol for Shuttle Box Test (TDPA)
The Shuttle Box Test for TDPA, or temporally dissociated passive avoidance, measures hippocampus-dependent associative learning by testing whether a rodent avoids entering a dark compartment that was previously paired with foot shock after a temporal delay between dark-compartment entry and shock delivery. The main behavioral readout is crossover or step-through latency from the light chamber into the dark chamber; increased latency across training or retention trials reflects learned avoidance memory rather than motor performance alone.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Protocol for Water Maze
The Morris Water Maze is a rodent spatial learning and memory assay in which a mouse or rat swims in opaque water to find an escape platform; in the hidden-platform version, the animal cannot see the platform and must use distal extra-maze cues to learn its fixed spatial location. The assay primarily measures hippocampus-dependent spatial learning during acquisition trials and spatial reference memory during probe trials after platform removal; readouts include escape latency, swim path length, swim speed, quadrant occupancy, platform-site crossings, and proximity to the former platform location.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
How to Choose the Right Model Animal
Choosing the right model animal is a validity-driven decision in which the species, strain, sex, age, genetic background, disease-induction method, outcome measures, and welfare burden must match the scientific question rather than laboratory tradition or convenience. A model should be selected by judging face validity, construct validity, and predictive validity: whether it resembles the human phenotype, whether it reproduces relevant mechanisms, and whether results are likely to predict human biology or treatment response. Animal studies often fail to translate because of species differences, weak disease resemblance, poor experimental design, inadequate reporting, publication bias, and underuse of randomization, blinding, and sample-size justification. Unresolved questions include how to rank competing models objectively, how much human-disease complexity must be reproduced for a given objective, and when non-animal systems such as organoids, ex vivo tissue, or computational models
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- H3R antagonist 4
- Apoptosis
- Cholinesterase (ChE)
- Tau Protein
- Ferroptosis
- Histamine Receptor
- Antioxidant activity
- H3R receptor antagonistic activity
- Neuroprotective effects of cell damage
- PC12 cells
- Reactive oxygen species production
- Blood-brain barrier permeability in vitro
- Anti-inflammatory in vitro
- Inhibitor
- inhibitor
- inhibit